Features

View all stories of the same content type.

  • Features

    Solvency II: A costly business

    2009-07-07T00:00:00Z

    No one will make it official, but the new regulatory framework could cost the industry far more than an old estimate of €3bn. Liz Booth reports.

  • Features

    Sanctions

    2009-06-11T00:00:00Z

    When sanctions are brought to bear, compliance can be onerous, complex, and even logically impossible. Victor Fornasier and Nina Tulloch give some advice.

  • Features

    Free Willi

    2009-06-11T00:00:00Z

    Wilhelm “Willi” Zeller retires as CEO of Hannover Re this month. But he is full of future plans.

  • Features

    Bermuda Triangle

    2009-06-11T00:00:00Z

    With a tug of war triangle over IPC/Max, and the viability of business models called into question, the Bermudian market finds itself in uncharted waters, writes Roger Crombie.

  • Features

    A message from our sponsor

    2009-05-27T00:00:00Z

    Welcome to Global Reinsurance’s Technology special report, in which you will read about the Lloyd’s Exchange, Qatar Insurance Services, and the impact of new technology on brokers.

  • Features

    No legacy

    2009-05-27T00:00:00Z

    Qatar Insurance Services plans to take its new market from manual slow to electronic fast. And it has the advantage of no legacy to overcome, writes Lynley Oram.

  • Features

    Heightened scrutiny

    2009-05-27T00:00:00Z

    The EU’s block exemption ruling is likely to be renewed – for some forms of co-operation. But there’s still a chance for the industry to have its say before the new ruling becomes law, write Guy Soussan, Yves Botteman, Angus Rodger and Gavin Coull.

  • Features

    Solvency II: where now for group support?

    2009-05-27T00:00:00Z

    Is it the end for group support under Solvency II? The linchpin of European insurance harmonisation could soon be back, writes David Banks.

  • Features

    No pain, no gain

    2009-05-27T00:00:00Z

    Sceptics must move with the times, write Helen Sainsbury and Simon Howden

  • Features

    Ruling removes FDA safety net

    2009-05-27T00:00:00Z

    The US Supreme Court has just removed one of the pharmaceutical industry’s main defences to product liability claims, write Angus Rodger, Gavin Coull and Gary Farmer